What is Alnylam Pharmaceuticals's EV / EBITDA?

Alnylam Pharmaceuticals (ALNY) reported EV / EBITDA of 52.6× in Q1 2026.

What does EV / EBITDA mean?

What the whole business (debt included) costs relative to its operating cash earnings.

How do you interpret EV / EBITDA?

Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.

How does EV / EBITDA compare across companies?

Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.

Alnylam Pharmaceuticals ALNY EV / EBITDA

EV / EBITDA at other companies

ModernaMRNA

50.1×+46.6×

Roivant SciencesROIV

1.8×—

IncyteINCY

9×-28.2×

AmgenAMGN

15.9×-1.3×

Royalty PharmaRPRX

13.9×+1.7×

Gilead SciencesGILD

17.5×-0.7×

Other financials

Income statement

See full

Revenue$1.2B+96.4%

Gross profit$959.7M+83.1%

Operating income$268.6M+1,386%

Net income$206.0M+1,229%

EPS (diluted)$1.51+1,179%

Balance sheet

See full

Cash & equivalents$1.7B+67.5%

Total debt$263.7M-4.5%

Total equity$1.1B+152%

Total assets$5.1B+21.7%

Cash flow

See full

Operating cash flow$70.5M+159%

CapEx$21.8M+143%

Free cash flow$48.7M+138%

Valuation

See full

Market cap$37.75B+25.6%

Enterprise value$36.3B+24.1%

P/E75.1×—

P/S8.8×-4.0×

Profitability

See full

Gross margin81%-5.3pp

Operating margin17.5%+14.4pp

Net margin11.7%+8.0pp

Returns & leverage

See full

Return on equity66.9%—

Debt / equity0.2×-0.4×

Current ratio3.1×+0.1×

Where this comes from

Calculated from Alnylam Pharmaceuticals’s reported figures.

enterprise value/ebitda=52.6×

Based on the most recent quarter.

The official record: Alnylam Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alnylam Pharmaceuticals's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alnylam Pharmaceuticals's EV / EBITDA?: Alnylam Pharmaceuticals (ALNY) reported EV / EBITDA of 52.6× in Q1 2026.
What does EV / EBITDA mean?: What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?: Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?: Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.